Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, 2-period, Crossover, Sleep Laboratory Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Patients With Obstructive Sleep Apnea
Conditions
Interventions
Seltorexant 40 mg
Placebo
Locations
4
United States
NeuroTrials Research, Inc.
Atlanta, Georgia, United States
Clinilabs
New York, New York, United States
CTI Clinical Trial and Consulting Services
Cincinnati, Ohio, United States
AMR New Orleans, Formerly New Orleans Center for Clinical Research - New Orleans, an AMR company
Knoxville, Tennessee, United States
Start Date
January 4, 2019
Primary Completion Date
June 7, 2019
Completion Date
June 14, 2019
Last Updated
April 27, 2025
NCT07446634
NCT03109171
NCT07191314
NCT05497180
NCT04712656
NCT03860233
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions